Breast Cancer Screening in Women with Sickle Cell Disease: A Single-Center Exploratory Study

Eiman Elmileik,Marwah Farooqui,Xu Zhang,Faiz Hussain,Rayyan Haqqani,Kaitlin Sung,Santosh L Saraf
DOI: https://doi.org/10.1093/jscdis/yoae009
2024-01-01
Abstract:Abstract Background Sickle cell disease is one of the most common inherited blood disorders and is associated with reduced life expectancy. As a result of prophylactic and disease-modifying therapeutic advances, more patients are reaching adulthood and mid-life, and research focusing on cancer screenings becomes more relevant. This study aims to identify patterns regarding breast cancer screening and breast composition in women with sickle cell disease. Methods This was a single-center retrospective study. Medical records of 156 individuals with sickle cell disease between 2018 and 2022 were analyzed. Results Of 156 individuals, 56% had screening mammography within the past two years. In comparison, the latest Centers for Disease Control and Prevention report showed that 70.8% of non-Hispanic Black women aged 40 and over had screening mammography within the past two years. The difference was not statistically significant; 54% of those screened had dense breasts. There was an inverse relationship between body mass index and breast density. Conclusion The results suggest that there was not a statistically significant difference in breast cancer screening rates between women with sickle cell disease and their counterparts without sickle cell disease. Our study found that there was an inverse relationship between body mass index and breast density in women with sickle cell disease which was consistent with well-established data about breast density and body mass index in the general female population. Prospective studies with larger cohorts are recommended to enhance statistical power, fostering a comprehensive understanding of cancer and cancer risk in individuals with sickle cell disease.
What problem does this paper attempt to address?